The Pulse of New York Tech
Bexson Biomedical is developing a unique formulation of ketamine for chronic and acute pain disorders. Founded in 2016, Bexson Biomedical is backed by investors that include Noetic Fund and is headquartered in Santa Barbara.
WRITE FOR US
NYC TECH EVENTS
NYC TECH NEWS
Join the millions and keep up with the stories shaping entrepreneurship. Sign up today.